
Healthcare sector · NSE / BSE
Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.
Price Band
₹382 – ₹402
Issue Size
₹3027 Cr
Lot Size
35 shares
GMP
-1.0%
Est. Listing
₹398
at current GMP
Subscribed
1.55x
overall
Open
29 Jan 2025
Close
31 Jan 2025
Allotment
1 Feb 2025
Refund
2 Feb 2025
Demat Credit
3 Feb 2025
Listing
4 Feb 2025
Designated Registrar: Kfin Technologies Limited
Allotment Date
1 Feb 2025
Basis finalization
Refunds Initiate
2 Feb 2025
Mandate release
Demat Credit
3 Feb 2025
Shares in demat
Listing Debut
4 Feb 2025
Trading begins
Dr. Agarwals Health Care Limited is bringing an initial public offering (IPO) in the Healthcare sector sector with an aggregate issue size of ₹3,027.26 Crores. The shares are offered at a price band of ₹382 to ₹402 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 35 shares (approx. ₹14,070 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-03, while un-allotted funds or UPI block mandates will be released on 2025-02-02.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.